Autres langues GSK plc Deutsche Boerse AG

Actions

GS71

GB00BN7SWP63

Produits pharmaceutiques

Marché Fermé - Deutsche Boerse AG 14:14:12 06/10/2026			Après clôture 21:59:54
20,84 ^EUR	+0,87%		20,78	-0,26%

17:48	Les actions européennes clôturent en hausse mardi sur fond de troubles politiques en France et en Espagne	MT
17:41	Cabenuva de ViiV Healthcare, soutenue par GSK, atteint son critère d’évaluation principal dans un essai clinique avancé sur le VIH	MT

Autres langues

17:48	European Stocks Close Higher in Tuesday Trading Amid Political Unrest in France, Spain
17:41	GSK-backed ViiV Healthcare's Cabenuva Meets Primary Endpoint in Late-stage HIV Trial
16:29	GSK celebrates "important insights" from Cabenuva study
15:49	GSK's ViiV Healthcare Says HIV Treatment Cabenuva's Latest Trial Meets Primary Endpoint
15:01	ViiV Healthcare’s long-acting HIV treatment Cabenuva (cabotegravir + rilpivirine) meets primary endpoint of superior viral suppression vs. daily oral therapy in people with viremia
05/10	European Equities Traded in the US as American Depositary Receipts Track Lower in Monday Trading
02/10	Major drugmakers turn to China for licensing deals
30/09	European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
30/09	Major drugmakers turn to China for licensing deals
30/09	Wave Life Sciences Earns $12 Million Milestone as GSK Advances Liver Drug
30/09	Wave Life Sciences, Inc. Announces GSK?s Selection Of siRNA Program To Transition To GSK For Further Development
30/09	Lonza nominiert Pearl Huang für Verwaltungsrat - Mäder geht
29/09	Pharma sector doubles down on AI to slash costs, timelines
29/09	Stocks rise as oil prices edge down
29/09	FTSE 100 hits two-week low as energy stocks slide
29/09	WINNERS & LOSERS: Vesuvius soars on bid; Zigup lifts outlook
29/09	Stocks rise as pharma and miners advance
28/09	AN2 Therapeutics, Inc. Announces Extension of Funding for Tuberculosis Research Collaboration with GSK
28/09	AN2 Therapeutics Gets Gates Foundation Funding Extension for Tuberculosis Research
28/09	Hutchmed begins phase Ia trial of HMPL-A830 in China
28/09	Hutchmed Doses First Patient in Early-Stage Trial of HMPL-A830 for Solid Tumors
28/09	Landsec sells London office; Entain holds guidance
28/09	Hutchmed Begins Phase Ia Clinical Trial of KRAS-EGFR Antibody Conjugate Cancer Therapy
25/09	FTSE 100 edges up as oil fall offsets bond worry
25/09	Singapore Pushes Local mRNA Vaccine Production to Boost Pandemic Preparedness